1. So!! AH: Medical treatment of peptic ulcer disease: Practice guidelines. JAMA 275:622, 1996.
2. Sontag SJ: Guilty as charged: Bugs and drugs in gastric ulcer. Am J Gastroenterol 92:1255, 199Z.
3. Rabeneck L, Graham DY: H. pylori: When to test, when to treat. Ann Intern Med 126:315, 199Z.
4. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR: Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 105:1378, 1993.
5. Sonnenberg A, Everhart JE: Health impact of peptic ulcer in the United States. Am J Gastroenterol 92:614, 1997.
6. NIH Consensus Development Panel: Helicobacter pylori in peptic ulcer disease. JAMA 272:65, 1994.
7. Talley NJ, McNeil D, Piper DW: Discriminant value of dyspeptic symptoms: A study of the clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis. Gut 28:40, 1987.
8. Damianos AJ, McGarrity TJ: Treatment strategies for Helicobacter pylori infection. Am Fam Physician 55:2765, 1997.
9. Forbes GM: Review: Helicobacter pylori: Current issues and new directions. J Gastroenterol Hepatol 12:419, 1997.
10. Falk GW: H. pylori 1997: Testing and treatment options. Cleveland Clin J Med 64:187, 1997.
11. Hirschowitz BI: Zollinger-Ellison syndrome: Pathogenesis, diagnosis, and management. Am J Gastroenterol 92(suppl):44S, 1997.
12. Werdmuller BFM, Van der Putten ABMM, Loffeld RJLF: Review: The clinical presentation of peptic ulcer disease. Neth J Med 50:115,1997.
13. Kemppainen H, Raiha I, Sourander L: Clinical presentation of peptic ulcer in the elderly. Gerontology 43:283, 1997.
14. De Boer WA: Diagnosis of Helicobacter pylori infection. Scand J Gastroenterol 223:35, 1997.
15. Drugs for treatment of peptic ulcers. Med Lett 39:1, 1997.
16. Graham DY, Rabeneck L: Patients, payers, and paradigm shifts: What to do about helicobacter pylori. Am J Gastroenterol 91:188, 1996.
17. Ofman JJ, Etchason J, Fullerton S, et al: Management strategies for Helicobacter pylori seropositive patients with dyspepsia: Clinical and economic consequences. Ann Intern Med 126:280, 1997.
18. Fendrick AM, Chernew ME, Hirth RA, Bloom BS: Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 123:260, 1995.
19. Jiranek GC, Kozarek RA: A cost-effective approach to the patient with peptic ulcer bleeding. Surg Clin North Am 76:83, 1996. 20. Lee JG, Leung JW: Therapeutic modalities for treatment of peptic ulcer bleeding. Gastroenterologist 5:26, 1997.
Was this article helpful?
Gastroesophageal reflux disease is the medical term for what we know as acid reflux. Acid reflux occurs when the stomach releases its liquid back into the esophagus, causing inflammation and damage to the esophageal lining. The regurgitated acid most often consists of a few compoundsbr acid, bile, and pepsin.